title: Tumor-primed, in vitro-activated CD4+ effector T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure.
abstract: Tumor-reactive T cells can be primed in vivo, then activated in vitro to provide numerical expansion and uniform acquisiton of effector phenotype and function. Adoptive transfer of effector T cells mediates complete regression of established tumors in animal models. Some experimental models indicate that extensive in vitro proliferation of T cells inhibits efficacy and that central memory T cells (T(CM)) provide greater activity than effector memory T cells (T(EM)). Clinical studies also demonstrate that persistence of adoptively transferred T cells is associated with therapeutic response, thus identifying that conditions to maximize effector cell numbers yet retain memory function are important. In this article, we demonstrate that adoptive transfer of in vitro activated effector CD4(+) T cells into tumor-free congenic mice mediates rejection of tumor challenge 9 mo later, at which time T cells re-express activation markers and undergo rapid proliferation at tumor sites. Analysis of the phenotype of memory cells in lymphoid tissues following adoptive transfer shows high CD44 expression with heterogeneous expression of CD62L, indicating a mixture of T(EM) and T(CM) phenotypes. Memory cells were sorted into two subsets based on CD62L expression levels and then activated in vitro. Although T(EM) cells proliferated more rapidly, T(EM) and T(CM) cells acquired effector phenotype and function. These data indicate that controlled in vitro expansion of tumor-reactive T cells for adoptive immunotherapy also provides a competent memory response.
authors.affiliation: Department of Immunology, Cleveland Clinic, Cleveland, OH 44195, USA.
authors.forename: Li-Xin
authors.initials: LX
authors.lastname: Wang
authors.forename: Gregory E
authors.initials: GE
authors.lastname: Plautz
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage* / Q000502:physiology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000473:pathology / Q000637:transplantation*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D016207:Cytokines / Q000008:administration & dosage / Q000502:physiology; D005260:Female; D005354:Fibrosarcoma / Q000276:immunology / Q000473:pathology / Q000556:secondary / Q000628:therapy; D007156:Immunologic Memory; D016219:Immunotherapy, Adoptive / Q000379:methods; D019041:L-Selectin / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology; D008175:Lung Neoplasms / Q000276:immunology / Q000473:pathology / Q000556:secondary / Q000628:therapy; D008198:Lymph Nodes / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008213:Lymphocyte Activation / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation / Q000276:immunology / Q000473:pathology
chemical_list: D000951:Antigens, Neoplasm; D016207:Cytokines; D019041:L-Selectin
references.citation: Nature. 2007 Dec 6;450(7171):903-7
references.pmid: 18026089
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2346-57
references.pmid: 15800326
references.citation: J Immunother. 2005 May-Jun;28(3):258-67
references.pmid: 15838383
references.citation: J Immunol. 2004 Dec 15;173(12):7125-30
references.pmid: 15585832
references.citation: J Immunol. 2002 Nov 1;169(9):4811-21
references.pmid: 12391191
references.citation: Immunity. 2005 Mar;22(3):371-83
references.pmid: 15780993
references.citation: Nat Rev Immunol. 2006 May;6(5):383-93
references.pmid: 16622476
references.citation: Blood. 2007 Oct 15;110(8):2838-45
references.pmid: 17609424
references.citation: Annu Rev Immunol. 2007;25:171-92
references.pmid: 17129182
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16689-94
references.pmid: 18946035
references.citation: Curr Opin Immunol. 2004 Jun;16(3):259-63
references.pmid: 15134772
references.citation: Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9571-6
references.pmid: 15980149
references.citation: Science. 2009 Jan 23;323(5913):505-9
references.pmid: 19164749
references.citation: Science. 1999 Nov 12;286(5443):1381-3
references.pmid: 10558997
references.citation: Immunity. 2008 Apr;28(4):533-45
references.pmid: 18356084
references.citation: Nat Med. 2001 Aug;7(8):913-9
references.pmid: 11479623
references.citation: Nature. 2009 Jul 2;460(7251):108-12
references.pmid: 19543266
references.citation: J Transl Med. 2004 Nov 26;2(1):41
references.pmid: 15566571
references.citation: Nat Immunol. 2004 Sep;5(9):927-33
references.pmid: 15300249
references.citation: J Immunol. 2004 Dec 1;173(11):6694-702
references.pmid: 15557161
references.citation: Immunity. 2008 Dec 19;29(6):848-62
references.pmid: 19100699
references.citation: Annu Rev Immunol. 2007;25:243-65
references.pmid: 17129181
references.citation: Science. 1995 Apr 7;268(5207):106-11
references.pmid: 7535476
references.citation: J Immunol. 2002 Feb 15;168(4):1528-32
references.pmid: 11823476
references.citation: J Immunol. 2000 Oct 1;165(7):3656-62
references.pmid: 11034369
references.citation: Nat Rev Cancer. 2008 Apr;8(4):299-308
references.pmid: 18354418
references.citation: J Immunol. 2004 Mar 15;172(6):3462-8
references.pmid: 15004146
references.citation: Blood. 2007 Jun 15;109(12):5346-54
references.pmid: 17327412
references.citation: Immunity. 2004 Aug;21(2):137-48
references.pmid: 15308095
references.citation: Immunity. 2007 Oct;27(4):670-84
references.pmid: 17950003
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16168-73
references.pmid: 12427970
references.citation: J Clin Invest. 2008 Jan;118(1):294-305
references.pmid: 18060041
references.citation: J Immunol. 1990 Feb 15;144(4):1531-7
references.pmid: 2303716
references.citation: Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):652-6
references.pmid: 18178624
references.citation: Blood. 2007 Jun 1;109(11):4865-76
references.pmid: 17284532
references.citation: PLoS One. 2009;4(3):e4749
references.pmid: 19270751
references.citation: J Exp Med. 2005 May 16;201(10):1555-65
references.pmid: 15897273
references.citation: Cancer Res. 1996 Oct 1;56(19):4338-42
references.pmid: 8813119
references.citation: J Clin Oncol. 2008 Nov 10;26(32):5233-9
references.pmid: 18809613